Table:
begin	end	state
1	31	cytoplasmic
32	52	transmembrane
53	62	non-cytoplasmic
63	86	transmembrane
87	97	cytoplasmic
98	117	transmembrane
118	121	non-cytoplasmic
122	146	transmembrane
147	166	cytoplasmic
167	188	transmembrane
189	197	non-cytoplasmic
198	217	transmembrane
218	259	cytoplasmic
260	278	transmembrane
279	297	non-cytoplasmic
298	316	transmembrane
317	326	cytoplasmic
327	346	transmembrane
347	351	non-cytoplasmic
352	375	transmembrane
376	386	cytoplasmic
387	411	transmembrane
412	416	non-cytoplasmic
417	438	transmembrane
439	500	cytoplasmic

Input:
>BWI76_RS02250
MLKRKKVKPITLRDVTIIDDSKLKKAITAASLGNAMEWFDFGVYGFVAYALGKVFFPDAN
PSVQMIAALGTFSVPFLIRPLGGLFFGMLGDKYGRQKILAITIVIMSISTFCIGLIPSYA
TIGIWAPILLLLCKMAQGFSVGGEYTGASIFVAEYSPDRKRGFMGSWLDFGSIAGFVMGA
GVVVLISSVVGEENFLSWGWRIPFFLALPLGIIGLYLRHALEETPAFQQHVDKMEQGDRE
GLQEGPKVSFKEIATKHWRSLLTCIGLVISTNVTYYMLLTYMPSYLSHNLHYSEDHGVLI
IIAIMVGMLFVQPVIGMLSDRFGRRPFILIGSVALFALSIPAFIMINSNVLGLIFAGLLV
LAVVLNCFIGVMASSLPAMFPTHIRFSALASAFNISVLIAGLTPTLAAWLVESTQNLMMP
AYYLMVIAVIGLITGLSMKETANRPLKGATPAASDIQEAKEILGEHYDNIEHKIEDIDQE
IADLQEKRSRLVQQHPRIND

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server